Transcription factors in myeloid development: balancing differentiation with transformation
The DOI matches its Crossref record; 141 of the 142 references it cites were found in a registry or an index.
Abstract
In recent years, great progress has been made in elucidating the progenitor-cell hierarchy of the myeloid lineage. Transcription factors have been shown to be key determinants in the orchestration of myeloid identity and differentiation fates. Most transcription factors show cell-lineage-restricted and stage-restricted expression patterns, indicating the requirement for tight regulation of their activities. Moreover, if dysregulated or mutated, these transcription factors cause the differentiation block observed in many myeloid leukaemias. Consequently, therapies designed to restore defective transcription factor functions are an attractive option in the treatment of myeloid and other human cancers.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Moreover, downregulation of PU.1 was identified as a mechanism for the induction of leukemias generated by PML-RARa, FLT3-ITD, and AML1-ETO.[43][44][45]”
From USP22 deficiency leads to myeloid leukemia upon oncogenic Kras activation through a PU.1-dependent mechanism (2018) · cites this paper as [43]
In the citing paper
“PU.1, a non-canonical pioneer transcription factor that functions as a master regulator of myeloid and lymphoid lineage differentiation18–20.”
From Lymphoid gene expression supports neuroprotective microglia function (2025) · cites this paper as [18]
In the citing paper
“Irf8 promotes GM lineage differentiation.”
From Dissecting cell identity via network inference and in silico gene perturbation (2023) · cites this paper as [29]
In the citing paper
“In particular, Irf8 promotes monocyte differentiation as a lineage switch between monocyte and granulocyte bifurcation29.”
From Dissecting cell identity via network inference and in silico gene perturbation (2023) · cites this paper as [29]
In the citing paper
“All activated macrophages, regardless of polarization state, express high levels of the transcription factors runt-related transcription factor 1 (RUNX1) and PU.1, which are thought to represent global regulators of macrophage phenotypic expression [20–22].”
From Macrophage polarization: an opportunity for improved outcomes in biomaterials and regenerative medicine (2012) · cites this paper as [20]
Citations
Cites
A clonogenic common myeloid progenitor that gives rise to all myeloid lineages
Akashi, K., Traver, D., Miyamoto, T., & Weissman, I. L. (2000) · Nature · doi:10.1038/35004599 · Cited by 2,617 · cited 1×
“The first lymphoid progenitor population that is known to arise from MPPs is the common lymphoid progenitors (CLPs; LIN − IL-7Rα + SCA1 low KIT low”
BackgroundIdentification of Clonogenic Common Lymphoid Progenitors in Mouse Bone Marrow
Kondo, M., Weissman, I. L., & Akashi, K. (1997) · Cell · doi:10.1016/s0092-8674(00)80453-5 · Cited by 2,253
Long-Term Lymphohematopoietic Reconstitution by a Single CD34-Low/Negative Hematopoietic Stem Cell
Osawa, M., Hanada, K.-I., Hamada, H., & Nakauchi, H. (1996) · Science · doi:10.1126/science.273.5272.242 · Cited by 2,140
Okuda, T., van Deursen, J., Hiebert, S. W., Grosveld, G., & Downing, J. R. (1996) · Cell · doi:10.1016/s0092-8674(00)80986-1 · Cited by 1,856
Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages
Scott, E. W., Simon, M. C., Anastasi, J., & Singh, H. (1994) · Science · doi:10.1126/science.8079170 · Cited by 1,532
Differentiation and proliferation of hematopoietic stem cells
Ogawa, M. (1993) · Blood · doi:10.1182/blood.v81.11.2844.2844 · Cited by 1,383
Identification of Flt3+ Lympho-Myeloid Stem Cells Lacking Erythro-Megakaryocytic Potential
Adolfsson, J., Månsson, R., Buza-Vidas, N., Hultquist, A., Liuba, K., Jensen, C. T., Bryder, D., Yang, L., Borge, O.-J., Thoren, L. A. M., et al. (2005) · Cell · doi:10.1016/j.cell.2005.02.013 · Cited by 1,236
Oncogenic Transcription Factors in the Human Acute Leukemias
Look, A. T. (1997) · Science · doi:10.1126/science.278.5340.1059 · Cited by 1,187
Targeted disruption of the PU.1 gene results in multiple hematopoietic abnormalities
McKercher, S. R., Torbett, B. E., Anderson, K. L., Henkel, G. W., Vestal, D. J., Baribault, H., Klemsz, M., Feeney, A. J., Wu, G. E., Paige, C. J., et al. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00949.x · Cited by 1,130
A Clonogenic Bone Marrow Progenitor Specific for Macrophages and Dendritic Cells
Fogg, D. K., Sibon, C., Miled, C., Jung, S., Aucouturier, P., Littman, D. R., Cumano, A., & Geissmann, F. (2006) · Science · doi:10.1126/science.1117729 · Cited by 1,053
Research works printed but not linked: 1
- Iwasaki, H. et al. Distinctive and indispensable roles of PU.1 in maintenance of hematopoietic stem cells and their differentiation. Blood 106, 1590–1600 (2005). · DOI · Paper page
Cited by
Items 301–400 of 608
Kim, Y., Lee, Y., Lee, M. N., Nah, J., Yun, N., Wu, D., & Pae, M. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1054875 · Cited by 26
Defective G-CSFR Signaling Pathways in Congenital Neutropenia
Skokowa, J., & Welte, K. (2012) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2012.11.001 · Cited by 26
Oostendorp, R. A. J., Gilfillan, S., Parmar, A., Schiemann, M., Marz, S., Niemeyer, M., Schill, S., Hammerschmid, E., Jacobs, V. R., Peschel, C., et al. (2008) · Stem Cells · doi:10.1634/stemcells.2007-1049 · Cited by 24
Cassinat, B., Zassadowski, F., Ferry, C., Llopis, L., Bruck, N., Lainey, É., Duong, V., Cras, A., Despouy, G., Chourbagi, O., et al. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.00756-10 · Cited by 25
“This long process is under close regulation orchestrated by numerous factors, among which cytokines, such as circulating granulocyte colony-stimulating factor (G-CSF) (38) and several transcription factors, such as nuclear retinoic acid (RA) receptors (RARs), play important roles (17, 41).”
BackgroundTranscription factors in autoimmune diseases
Stanford, L. P. (2008) · Frontiers in bioscience · doi:10.2741/3001 · Cited by 23
“Since a detailed review of these processes extends beyond the scope of this review, the reader is directed to one of several reviews for further details (1-8).”
BackgroundZhao, X., Liu, H., Wang, L., Yang, L., & Liu, X. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.11.010 · Cited by 25
Kiuchi, M., Onodera, A., Kokubo, K., Ichikawa, T., Morimoto, Y., Kawakami, E., Takayama, N., Eto, K., Koseki, H., Hirahara, K., et al. (2021) · The Journal of Experimental Medicine · doi:10.1084/jem.20201690 · Cited by 24
Villela, L., & Bolaños‐Meade, J. (2011) · Drugs · doi:10.2165/11593060-000000000-00000 · Cited by 22
“CEBPA is a transcription factor that it is in charge of regulating proliferation and differentiation in myeloid cells.([27,28]) Patients with AML and normal karyotype who also have a double (biallelic) mutation have a better risk AML.”
BackgroundJose, S. S., Tidu, F., Búřilová, P., Kepák, T., Bendíčková, K., & Frič, J. (2018) · Frontiers in Genetics · doi:10.3389/fgene.2018.00345 · Cited by 25
“TERC Deficiency in iPSC-Derived Myeloid Cells Affects the Expression of Transcription Factors Controlling Myelopoiesis To understand which factors could change the potential of shTERC iPSCs to differentiate into myeloid cells, we analyzed the expression of a group of known transcription factors involved in myelopoiesi…”
BackgroundMicroglia across evolution: from conserved origins to functional divergence
Shimizu, T., & Prinz, M. (2025) · Cellular and Molecular Immunology · doi:10.1038/s41423-025-01368-6 · Cited by 30
“PU.1, encoded by Spi1 , is a founding member of the E26-transformation-speci fi c (ETS) family and acts as a master regulator of myelopoiesis [54, 55].”
Recent advances in transcription factor assays in vitro
Zhang, Y., Ma, F., Tang, B., & Zhang, C. (2016) · Chemical Communications · doi:10.1039/c5cc09891b · Cited by 22
Transcriptional reprogramming by mutated IRF4 in lymphoma
Schleußner, N., Cauchy, P., Franke, V., Giefing, M., Fornés, O., Vankadari, N., Assi, S. A., Costanza, M., Weniger, M. A., Akalin, A., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-41954-8 · Cited by 27
Mai, S., Hodges, A., Chen, H.-M., Zhang, J., Wang, Y.-L., Liu, Y., Nakatsu, F., Wang, X., Fang, J., Xu, Y., et al. (2023) · Cancer Research · doi:10.1158/0008-5472.can-22-2483 · Cited by 21
Jensen, H. A., Yourish, H. B., Bunaciu, R. P., Varner, J. D., & Yen, A. (2015) · FEBS Open Bio · doi:10.1016/j.fob.2015.09.008 · Cited by 30
“1 and C/EBPa, in myelomonocytic lineage selection have been well characterized via knockout, antisense and overexpression studies [5-7].”
BackgroundYi, S., Wen, L., He, J., Wang, Y., Zhao, F., Zhao, J. J., Zhao, Z., Cui, G., & Chen, Y. (2014) · Annals of Hematology · doi:10.1007/s00277-014-2206-x · Cited by 22
Shin, J., Bourdon, C., Bernard, M., Wilson, M. D., Reischl, E., Waldenberger, M., Ruggeri, B., Schumann, G., Desrivières, S., Leemans, A., et al. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv294 · Cited by 24
“known as SPI1) is amaster transcription factor critical formyeloid hematopoiesis (29), as well as for the development and function ofmicroglia, themain resident immune cells of the brain (43–45).”
BackgroundPirin downregulation is a feature of AML and leads to impairment of terminal myeloid differentiation
Licciulli, S., Cambiaghi, V., Scafetta, G., Gruszka, A., & Alcalay, M. (2009) · Leukemia · doi:10.1038/leu.2009.247 · Cited by 22
Haas, S. C., Huber, R., Gutsch, R., Kandemir, J. D., Cappello, C., Krauter, J., Duyster, J., Ganser, A., & Brand, K. (2009) · British Journal of Haematology · doi:10.1111/j.1365-2141.2009.08012.x · Cited by 24
“It has been suggested that the transcription factor C/EBPb, belonging to the C/EBP family, plays a crucial role in malignant disease (Ramji & Foka, 2002; Jundt et al, 2005), similar to its relative C/EBPa (Pabst et al, 2001; Rosenbauer & Tenen, 2007).”
BackgroundXu, S., Wang, T., Hu, X., Deng, H. X., Zhang, Y., Xu, L., Zeng, Y., Yu, J., Zhang, W., Wang, L., et al. (2025) · Science Advances · doi:10.1126/sciadv.ado3923 · Cited by 27
“S16), the typical transcription factors controlling the granulocyte differentiation, and the KLF4 that critically regulates the monocyte differentiation ( 46 , 47 ).”
miR-155 regulative network in FLT3 mutated acute myeloid leukemia
Salemi, D., Cammarata, G., Agueli, C., Augugliaro, L., Corrado, C., Bica, M. G., Raimondo, S., Marfia, A., Randazzo, V., Dragotto, P., et al. (2015) · Leukemia Research · doi:10.1016/j.leukres.2015.04.017 · Cited by 26
The Role of PLZF in Human Myeloid Development
Dick, J. E., & Doulatov, S. R. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.04965.x · Cited by 24
Cabanski, M., Fields, B., Boué, S., Boukharov, N., León, H. D., Dror, N., Geertz, M., Guedj, E., Iskandar, A. R., Kogel, U., et al. (2015) · Inflammation Research · doi:10.1007/s00011-015-0820-2 · Cited by 21
“We applied this approach based on the assumption that regulatory activity (such as DNA-binding ability) of a TF strongly depends on its protein abundance [40, 41].”
MethodZheng, S., Hedl, M., & Abraham, C. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1402808 · Cited by 23
“Runx1 and Runx2 have been well studied in cell proliferation and differentiation (47), and C/EBPa has been identified as a lineage-specific transcription factor in the hematopoietic system (48).”
BackgroundApolipoprotein A-I Protection Against Atherosclerosis Is Dependent on Genetic Background
Sontag, T. J., Krishack, P. A., Lukens, J. R., Bhanvadia, C. V., Getz, G. S., & Reardon, C. A. (2013) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.113.302831 · Cited by 22
“background on the stem cells from which these monocytes are derived (Figure 5C).(23) Both CE and CEA bone marrow tended”
BackgroundTemporal autoregulation during human PU.1 locus SubTAD formation
Schuetzmann, D., Walter, C., van Riel, B., Kruse, S., König, T., Erdmann, T., Tönges, A., Bindels, E. M., Weilemann, A., Gebhard, C., et al. (2018) · Blood · doi:10.1182/blood-2018-02-834721 · Cited by 20
Self-citationVitamin K2 modulates differentiation and apoptosis of both myeloid and erythroid lineages
Sada, E., Abe, Y., Ohba, R., Tachikawa, Y., Nagasawa, E., Shiratsuchi, M., & Takayanagi, R. (2010) · European Journal Of Haematology · doi:10.1111/j.1600-0609.2010.01530.x · Cited by 22
Technical Advance: Transcription factor, promoter, and enhancer utilization in human myeloid cells
Joshi, A., Pooley, C. M., Freeman, T. C., Lennartsson, A., Babina, M., Schmidl, C., Geijtenbeek, T. B. H., Michoel, T., Severin, J., Itoh, M., et al. (2015) · Journal of Leukocyte Biology · doi:10.1189/jlb.6ta1014-477rr · Cited by 20
“1 expression determines the developmental fate of a CMP [35].”
BackgroundInfluentialImpaired adult myeloid progenitor CMP and GMP cell function in conditional c-myb-knockout mice
Lieu, Y. K., & Reddy, E. P. (2012) · Cell Cycle · doi:10.4161/cc.21802 · Cited by 20
“Dysregulation or mutation of some of these transcription factors is often associated with myeloid leukemias.(2) The c-myb proto-oncogene is the founding member of the myb family of transcription factors.”
BackgroundThe autophagy scaffold protein ALFY is critical for the granulocytic differentiation of AML cells
Schläfli, A. M., Isakson, P., Garattini, E., Simonsen, A., & Tschan, M. P. (2017) · Scientific Reports · doi:10.1038/s41598-017-12734-4 · Cited by 22
Role of microRNAs in myeloid differentiation
Fatica, A., Rosa, A., Ballarino, M., Marchis, M. L. D., Rasmussen, K. D., & Bozzoni, I. (2008) · Biochemical Society Transactions · doi:10.1042/bst0361201 · Cited by 22
Molecular analysis of the bovine anaphylatoxin C5a receptor
Nemali, S., Siemsen, D. W., Nelson, L. K., Bunger, P. L., Faulkner, C. L., Rainard, P., Gauss, K. A., Jutila, M. A., & Quinn, M. T. (2008) · Journal of Leukocyte Biology · doi:10.1189/jlb.0208142 · Cited by 18
“1 [42], suggesting an important role for this factor in regulating C5aR expression.”
BackgroundTurkalj, S., Jakobsen, N. A., Groom, A., Metzner, M., Riva, S. G., Gür, E. R., Usukhbayar, B., Salazar, M. A., Hentges, L. D., Mickute, G., et al. (2023) · Cell Stem Cell · doi:10.1016/j.stem.2023.04.012 · Cited by 20
Watanabe‐Okochi, N., Yoshimi, A., Sato, T., Ikeda, T., Kumano, K., Taoka, K., Satoh, Y., Shinohara, A., Tsuruta-Kishino, T., Masuda, A., et al. (2013) · Blood · doi:10.1182/blood-2011-07-368654 · Cited by 22
Inhibition of Ras-mediated signaling pathways in CML stem cells
Bertacchini, J., Ketabchi, N., Mediani, L., Capitani, S., Marmiroli, S., & Saki, N. (2015) · Cellular Oncology · doi:10.1007/s13402-015-0248-2 · Cited by 19
“which in turn may induce changes in gene expression [71].”
BackgroundDecoding early myelopoiesis from dynamics of core endogenous network
Su, H., Wang, G., Yuan, R., Wang, J., Tang, Y., Ao, P., & Zhu, X. (2017) · Science China Life Sciences · doi:10.1007/s11427-017-9059-y · Cited by 23
Myeloid leukemia with transdifferentiation plasticity developing from T‐cell progenitors
Riemke, P., Czéh, M., Fischer, J., Walter, C., Ghani, S., Zepper, M., Agelopoulos, K., Lettermann, S., Gebhardt, M. L., Mah, N., et al. (2016) · The EMBO Journal · doi:10.15252/embj.201693927 · Cited by 20
“Because cell-specific gene programs are mainly regulated by transcription factors (Rosenbauer & Tenen, 2007; Rothenberg et al , 2008), we searched for genes in the thymic memory that encode transcription factors and identified Bcl11b and Gata3 as two promising candidates (Sambandam et al , 2005;…”
Self-citationMicrobial Sensing by Hematopoietic Stem and Progenitor Cells
Barman, P. K., & Goodridge, H. S. (2022) · Stem Cells · doi:10.1093/stmcls/sxab007 · Cited by 20
Epigenetic Memories in Hematopoietic Stem and Progenitor Cells
Aoyama, K., Itokawa, N., Oshima, M., & Iwama, A. (2022) · Cells · doi:10.3390/cells11142187 · Cited by 21
“Emergency myelopoiesis is driven via the activation of key myeloid transcriptional networks at the HSPC and myeloid progenitor cell levels [94].”
BackgroundEya2, a Target Activated by Plzf, Is Critical for PLZF-RARA -Induced Leukemogenesis
Ono, R., Masuya, M., Ishii, S., Katayama, N., & Nosaka, T. (2017) · Molecular and Cellular Biology · doi:10.1128/mcb.00585-16 · Cited by 18
“including hematological malignancies (3, 4).”
Mathematical Analysis of Cytokine-Induced Differentiation of Granulocyte-Monocyte Progenitor Cells
Weston, B. R., Li, L., & Tyson, J. J. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02048 · Cited by 19
Cevallos, R. R., Edwards, Y. J. K., Parant, J. M., Yoder, B. K., & Hu, K. (2020) · Scientific Reports · doi:10.1038/s41598-020-76705-y · Cited by 16
PU.1 and CEBPA expression in acute myeloid leukemia
D’Alò, F., Ruscio, A. D., Guidi, F., Fabiani, E., Greco, M., Rumi, C., Hohaus, S., Voso, M. T., & Leone, G. G. M. (2008) · Leukemia Research · doi:10.1016/j.leukres.2008.01.007 · Cited by 17
Augmentation of iNOS expression in myeloid progenitor cells expedites neutrophil differentiation
Sadaf, S., Singh, A. K., Awasthi, D., Nagarkoti, S., Agrahari, A. K., Srivastava, R. N., Jagavelu, K., Kumar, S., Barthwal, M. K., & Dikshit, M. (2019) · Journal of Leukocyte Biology · doi:10.1002/jlb.1a0918-349rr · Cited by 17
Transcribing malignancy: transcription-associated genomic instability in cancer
Boulianne, B., & Feldhahn, N. (2017) · Oncogene · doi:10.1038/onc.2017.402 · Cited by 18
Ward, C., Cauchy, P., García, P., Frampton, J., Esteban, M. A., & Volpe, G. (2020) · Scientific Reports · doi:10.1038/s41598-020-60480-x · Cited by 19
Mapping Whole-Transcriptome Splicing in Mouse Hematopoietic Stem Cells
Goldstein, O., Meyer, K., Greenshpan, Y., Bujanover, N., Feigin, M., Ner‐Gaon, H., Shay, T., & Gazit, R. (2016) · Stem Cell Reports · doi:10.1016/j.stemcr.2016.12.002 · Cited by 17
“Genetic studies have made seminal discoveries, finding the mutations in genes that are associated with hematopoietic diseases (Rosenbauer and Tenen, 2007).”
BackgroundBoulianne, B., Robinson, M. E., May, P. C., Castellano, L., Blighe, K., Thomas, J., Reid, A. G., Müschen, M., Apperley, J. F., Stebbing, J., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.01.057 · Cited by 20
Enforced GFI1 expression impedes human and murine leukemic cell growth
Hönes, J. M., Thivakaran, A., Botezatu, L., Patnana, P. K., Castro, S. V. D. C., Al-Matary, Y. S., Schütte, J., Fischer, K. B. I., Vaßen, L., Görgens, A., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-15866-9 · Cited by 22
Multiomic single-cell profiling identifies critical regulators of postnatal brain
Clarence, T., Bendl, J. M., Cao, X. D., Wang, X., Zheng, S., Hoffman, G. E., Kozlenkov, A., Hong, A., Iskhakova, M., Jaiswal, M. K., et al. (2025) · Nature Genetics · doi:10.1038/s41588-025-02083-8 · Cited by 25
“…eGRNs recover well-known regulators of OL and OPC (MYRF, CREB5 and ASCL1, OLIG2, respectively) 24–27 , astrocytes (PAX6, SOX9) 28,29 , microglia (SPI1, IRF8, RUNX1) 30–35 , neurons (MEIS3 and NEUROD2, respectively) 36–40 , endothelial and pericyte/VLMC cells (family of FOX and ZIC TFs) 41,42 (Fig.”
Barbara, A., Katakura, F., & Belosevic, M. (2012) · InTech eBooks · doi:10.5772/53589 · Cited by 20
“The transcriptional regulation of mammalian hematopoiesis/myelopoiesis has been ex‐ tensively reviewed elsewhere [159-162], and will only be briefly described here for the pur‐ pose of putting advances in the teleost model systems into context.”
BackgroundWilkinson, A. C., Goode, D. K., Cheng, Y., Dickel, D. E., Foster, S., Sendall, T. J., Tijssen, M. R., Sánchez, M. J., Pennacchio, L. A., Kirkpatrick, A. M., et al. (2013) · Biology Open · doi:10.1242/bio.20136296 · Cited by 17
“The transcription factor Gfi1 is expressed in multiple tissues, including haematopoietic progenitors and stem cells, lymphoid and myeloid cells (Karsunky et al., 2002; Hock et al., 2004; Yücel et al., 2004; Rosenbauer and Tenen, 2007; Wilson et al., 2010a; Lancrin et al., 2012).”
BackgroundNamasu, C. Y., Katzerke, C., Bräuer-Hartmann, D., Wurm, A. A., Gerloff, D., Hartmann, J.-U., Schwind, S., Müller‐Tidow, C., Hilger, N., Fricke, S., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.22093 · Cited by 16
“AML involves activation of oncogenes or deactivation of tumor suppressor genes, and a block of differentiation caused by reduced function of transcription factors [2, 3].”
BackgroundIdentifying microRNA determinants of human myelopoiesis
Rajasekhar, M., Schmitz, U., Flamant, S., Wong, J. J. L., Bailey, C. G., Ritchie, W., Holst, J., & Rasko, J. E. J. (2018) · Scientific Reports · doi:10.1038/s41598-018-24203-7 · Cited by 17
Nucleic acid therapeutics as differentiation agents for myeloid leukemias
Kovecses, O., Mercier, F., & McKeague, M. (2024) · Leukemia · doi:10.1038/s41375-024-02191-0 · Cited by 23
“Furthermore, transcription factors that govern healthy myeloid differentiation (reviewed [5]) can also be fi ne-tuned using NATs to reprogram leukemic cells to a healthy phenotype.”
BackgroundFontemaggi, G., Bellissimo, T., Donzelli, S., Iosue, I., Benassi, B., Bellotti, G., Blandino, G., & Fazi, F. (2015) · RNA Biology · doi:10.1080/15476286.2015.1044194 · Cited by 15
“During hematopoiesis the cell lineage determination of haematopoietic progenitor cells (HPCs) is largely controlled by a unique combination of lineage specific transcription factors (TFs) that regulate in a cooperative way the activity of promoters and enhancers present on their target genes.(1,2) Interestingly, recen…”
BackgroundChromatin Dynamics during Differentiation of Myeloid Cells
Schönheit, J., Leutz, A., & Rosenbauer, F. (2014) · Journal of Molecular Biology · doi:10.1016/j.jmb.2014.08.015 · Cited by 19
Self-citationTCEA1 regulates the proliferative potential of mouse myeloid cells
Yang, T., Cui, H., Wen, M., Zuber, J. A., Kogan, S. C., & Wei, G. (2018) · Experimental Cell Research · doi:10.1016/j.yexcr.2018.07.020 · Cited by 16
“progenitors (CMPs) towards to granulocyte-monocyte progenitors (GMPs) [57].”
Young, P. P., Ardestani, S., & Li, B. (2010) · Cancer Microenvironment · doi:10.1007/s12307-010-0045-4 · Cited by 20
“Other important factors in differentiation of myeloid cells include transcription factors such as IRF8, cmyc, and c-myb [20, 27, 29].”
BackgroundPer2 Is a C/EBP Target Gene Implicated in Myeloid Leukemia
Gery, S., & Koeffler, H. P. (2009) · Integrative Cancer Therapies · doi:10.1177/1534735409352084 · Cited by 16
“Increasing evidence suggest that a small group of lineagespecific transcription factors have a key role in this process.(1) One family of transcription factors, important to the regulation of cell growth and differentiation in many cell types, including haematopoietic cells, are the CCAAT/enhancer-binding proteins (C/…”
BackgroundThe DC-derived protein DC-STAMP influences differentiation of myeloid cells
Eleveld-Trancikova, D., Janssen, R. A. J., Hendriks, I. A. M., Looman, M. W. G., Moulin, V., Jansen, B., Jansen, J., Figdor, C. G., & Adema, G. J. (2007) · Leukemia · doi:10.1038/sj.leu.2404910 · Cited by 15
Cell of origin epigenetic priming determines susceptibility to Tet2 mutation
Schiroli, G., Kartha, V. K., Duarte, F. M., Kristiansen, T. A., Mayerhofer, C., Shrestha, R., Earl, A., Hu, Y., Tay, T., Rhee, C., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-48508-6 · Cited by 16
“This analysis identi fi ed activators and repressors which regulate chromatin accessibility including many known TFs involved in differentiation (Runx1, Hlf and Tal1), GMP speci fi cation (Cebpa-b), effectors of myeloid cell function, (Nr4a1-3 and members of the Atf family 58,59 ) (Fig.”
microRNAs : role in leukemia and their computational perspective
Omer, A., Singh, P. C., Yadav, N. K., & Singh, R. K. (2014) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.1256 · Cited by 14
Mapping of MN1 Sequences Necessary for Myeloid Transformation
Kandilci, A., Surtel, J., Janke, L. J., Neale, G. A. M., Terranova, S., & Grosveld, G. C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061706 · Cited by 14
“[1,2] These genes mostly control the survival/proliferation/differentiation programs of the hematopoietic stem/progenitor cells (HSPC).”
BackgroundImpact of microRNA-130a on the neutrophil proteome
Pedersen, C. C., Refsgaard, J. C., Østergaard, O., Jensen, L. J., Heegaard, N. H. H., Borregaard, N., & Cowland, J. B. (2015) · BMC Immunology · doi:10.1186/s12865-015-0134-8 · Cited by 16
“Granulopoiesis is strictly regulated by transcription factors including RUNX1, C/EBPα, and C/EBPε [2–4].”
BackgroundHuber, R., Panterodt, T., Welz, B., Christmann, M., Friesenhagen, J., Westphal, A., Pietsch, D., & Brand, K. (2015) · PLoS ONE · doi:10.1371/journal.pone.0144338 · Cited by 14
“The importance of the regulation of the translational machinery during cellular differentiation has been recognised earlier [31], also with respect to maturation of monocytic cells [51].”
BackgroundPathogenesis of early leukemia and lymphoma
Zhao, X. F., Reitz, M. S., Chen, Q. C., & Stass, S. A. (2011) · Cancer Biomarkers · doi:10.3233/cbm-2011-0178 · Cited by 14
“1), which are believed to drive HSC formation from the mesoderm [307].”
Differential expression of Wnt13 isoforms during leukemic cell differentiation
Bunaciu, R. P., Tang, T., & Mao, C. D. (2008) · Oncology Reports · doi:10.3892/or.20.1.195 · Cited by 14
“…these early stages of hematopoietic cell differentiation, specific gene expression programs are driven by lineage-specific transcription factors (20,21) and are thus characterized by specific correlation patterns of co-regulation among the lineage-specific transcription factors, signaling…”
Ming, J., Jiang, T.-F., Wang, Y., & Lv, Z. (2016) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2016.01.102 · Cited by 14
Nauseef, W. M., & Clark, R. A. (2010) · Elsevier eBooks · doi:10.1016/b978-0-443-06839-3.00008-4 · Cited by 13
Buckley, B. A. (2011) · Journal of Comparative Physiology B · doi:10.1007/s00360-011-0572-4 · Cited by 13
“The expression patterns of the C/EBPs have been linked to changes in cell fate (Nerlov 2007), as some isoforms drive the maturation of given cell types such as hematopoietic cells down specific developmental trajectories (Rosenbauer and Tenen 2007; Gery and Koeffler 2009).”
BackgroundThe N-terminal CEBPA mutant in acute myeloid leukemia impairs CXCR4 expression
Kuo, Y., Hou, H., Chen, Y.-K., Li, L., Chen, P., Tseng, M.-H., Huang, C., Lee, F.-Y., Liu, M.-C., Liu, C.-W., et al. (2014) · Haematologica · doi:10.3324/haematol.2014.107821 · Cited by 13
“The leukemogenesis is a multi-step process involving accumulated genetic abnormalities and epigenetic deregulations that perturb gene expression and disrupt cell differentiation.(10) Transcription factors are main targets of mutations in AML.”
BackgroundWurm, A. A., Tenen, D. G., & Behre, G. (2017) · PLoS Genetics · doi:10.1371/journal.pgen.1006505 · Cited by 16
“An example is the myeloid transcription factor CEBPA: while under normal conditions it functions as a typical tumor suppressor and master regulator of myelopoiesis [13], it has been reported that its expression is crucial for mixed lineage leukemia (MLL) rearrangements to induce leukemia in mice [14, 15].”
BackgroundSelf-citationKelm, R. J., Lamba, G. S., Levis, J. E., & Holmes, C. E. (2017) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26369 · Cited by 13
“Much of the phenotypic diversity and heterogeneity of AML is because the genetic and epigenetic changes that ultimately lead to leukemic transformation can occur at a number of different steps along the differentiation pathway.(3,4) The single most important prognostic factor in AML is cytogenetics.”
BackgroundYokoyama, K., Shimizu, E., Yokoyama, N., Nakamura, S., Kasajima, R., Ogawa, M., Takei, T., Ito, M., Kobayashi, A., Yamaguchi, R., et al. (2018) · Blood Advances · doi:10.1182/bloodadvances.2017010744 · Cited by 13
“Acute myeloid leukemia (AML) is a clonal myeloid neoplasm that involves maturation arrest at the myeloid progenitor (MP) level and dysregulated proliferation of blast cells in the bone marrow (BM).(1) Although AML generally arises de novo, some cases evolve from a preleukemic state, such as myelodysplastic syndrome (M…”
BackgroundTranscriptional Factor PU.1 Regulates Decidual C1q Expression in Early Pregnancy in Human
Madhukaran, S. P., Kishore, U., Jamil, K., Teo, B. H. D., Choolani, M. A., & Lu, J. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00053 · Cited by 13
Halley, J. D., Winkler, D. A., & Burden, F. R. (2008) · Stem Cell Research · doi:10.1016/j.scr.2008.03.001 · Cited by 15
Polycomb repressive complex 1.1 coordinates homeostatic and emergency myelopoiesis
Nakajima‐Takagi, Y., Oshima, M., Takano, J., Koide, S., Itokawa, N., Uemura, S., Yamashita, M., Andoh, S., Aoyama, K., Isshiki, Y., et al. (2023) · eLife · doi:10.7554/elife.83004 · Cited by 13
“C/EBP family are master transcription factors for myeloid differentiation (Avellino & Delwel, 2017; Rosenbauer & Tenen, 2007).”
BackgroundATF2 orchestrates macrophage differentiation and activation to promote antibacterial responses
Rajabalee, N., Siushansian, H., Weerapura, M., Berton, S., Berbatovci, F., Hooks, B. G., Geoffrion, M., Yang, D., Harper, M., Rayner, K. J., et al. (2023) · Journal of Leukocyte Biology · doi:10.1093/jleuko/qiad076 · Cited by 14
Zhang, D., Li, Z., Htwe, Y. M., Shi, P., Wei, X., Nie, H., Nin, J., Wu, L., Khan, F. S., Yu, Q., et al. (2024) · Industrial Crops and Products · doi:10.1016/j.indcrop.2024.118338 · Cited by 15
PBAF lacking PHD domains maintains transcription in human neutrophils
Viryasova, G. M., Tatarskiy, V. V., Sheynov, A. A., Tatarskiy, E. V., Sud’ina, G. F., Georgieva, S. G., & Soshnikova, N. V. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2019.118525 · Cited by 13
Ritter, M. U., Klimiankou, M., Klimenkova, O., Schambach, A., Hoffmann, D., Schmidt, A. P., Kanz, L., Link, D. C., Welte, K., & Skokowa, J. (2020) · Annals of Hematology · doi:10.1007/s00277-020-04194-0 · Cited by 12
“1 is upregulated in hematopoietic cells of CN patients [40] and is an essential transcription factor for monocytic differentiation [41, 42].”
BackgroundHematopoietic Stem Cell Transcription Factors in Cardiovascular Pathology
Duddu, S., Chakrabarti, R., Ghosh, A., & Shukla, P. C. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.588602 · Cited by 18
Kayabaşı, Ç., Yelken, B. Ö., Aşık, A., Okcanoğlu, T. B., Söğütlü, F., Gasımlı, R., Süslüer, S. Y., Saydam, G., Avcı, Ç. B., & Gündüz, C. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.174446 · Cited by 14
Kim, M. S., Kang, J.-W., Park, Y. S., Lee, D. H., Bak, Y., Kwon, T., & Yoon, D. (2015) · Oncotarget · doi:10.18632/oncotarget.3013 · Cited by 14
“1, interferon regulatory transcription factor (IRF) family, CCAATenhancer-binding proteins (C/EBPs) and runt-related transcription factor 1 (RUNX1) [2–3].”
BackgroundThe role of micro-ribonucleic acids in normal hematopoiesis and leukemic T-lymphogenesis
Slavov, S. N., Teixeira, H. L. G., & Rego, E. M. (2010) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x2010007500057 · Cited by 13
“These HPCs generate common lymphoid progenitors, giving rise to B- and T-lymphocytes, and common myeloid progenitors, generating erythrocytes, megakaryocytes, granulocytes, and monocytes/macrophages (Figure 1) (18).”
BackgroundChen, J., Wu, W., & Zeng, L. (2014) · Analytical Methods · doi:10.1039/c4ay00323c · Cited by 12
Zhang, T., Lian, G., Fang, W., Tian, L., Ma, W., Zhang, J., Meng, Z., Yang, H., Wang, C., Wei, C., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1257572 · Cited by 15
Michaels, Y. S., Major, M. C., Bonham-Carter, B., Zhang, J.-Q., Heydari, T., Edgar, J. M., Siu, M. M., Greenstreet, L., Vilarrasa‐Blasi, R., Kim, S., et al. (2024) · Cell Systems · doi:10.1016/j.cels.2024.11.001 · Cited by 14
Shi, C., Miley, J., Nottingham, A., Morooka, T., Prosdocimo, D. A., & Simon, D. I. (2019) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2019.02.008 · Cited by 12
“1, CCAAT/enhancerbinding proteins (C/EBPs), early growth response-1 (EGR-1), MAF bZIP transcription factor B (MAFB), interferon regulatory factor-8/interferon consensus sequence-binding protein (IRF-8/ICSBP), and Kruppel-like factor-4 (KLF-4), have been implicated in monocyte differentiation (4, 5).”
BackgroundFleenor, C. J., Arends, T., Lei, H., Åhsberg, J., Okuyama, K., Kuruvilla, J., Cristóbal, S., Rabe, J. L., Pandey, A., Danhorn, T., et al. (2018) · Molecular and Cellular Biology · doi:10.1128/mcb.00603-17 · Cited by 12
COCOA: coordinate covariation analysis of epigenetic heterogeneity
Lawson, J. T., Smith, J. P., Bekiranov, S., Garrett-Bakelman, F. E., & Sheffield, N. C. (2020) · Genome biology · doi:10.1186/s13059-020-02139-4 · Cited by 10
“3, we 479 did a literature search, selecting three reviews: one focusing on myeloid TFs [49] , one focusing on 480 lymphoid TFs [50] and one general hematopoietic TF [51] .”
BackgroundInfluentialAref, S., Ibrahim, L., Morkes, H., Azmy, E., & Ebrahim, M. (2013) · Hematology · doi:10.1179/1607845412y.0000000065 · Cited by 12
PML is a key component for the differentiation of myeloid progenitor cells to macrophages
Khalfin-Rabinovich, Y., Weinstein, A., & Levi, B.-Z. (2011) · International Immunology · doi:10.1093/intimm/dxr004 · Cited by 13
Khan, M. (2010) · Expert Review of Proteomics · doi:10.1586/epr.10.38 · Cited by 12
DeLeo, F. R., & Nauseef, W. M. (2015) · Elsevier eBooks · doi:10.1016/b978-1-4557-4801-3.00008-4 · Cited by 12
Hasemann, M. S., Damgaard, I., Schuster, M. B., Theilgaard‐Mönch, K., Sørensen, A. B., Mršić, A., Krugers, T., Ylstra, B., Pedersen, F. S., Nerlov, C., et al. (2008) · Blood · doi:10.1182/blood-2007-06-097790 · Cited by 11
Pin1‐Mediated Prolyl Isomerization of Runx1 Affects PU.1 Expression in Pre‐Monocytes
Islam, R., Yoon, W., Woo, K. M., Baek, J., & Ryoo, H. (2013) · Journal of Cellular Physiology · doi:10.1002/jcp.24462 · Cited by 11
“The expression level of PU.1 is critical for specifying the hematopoietic cell fate (DeKoter and Singh, 2000; Carotta et al., 2010), and even moderate changes in PU.1 levels can lead to leukemias and lymphomas (Rosenbauer et al., 2004; Mak et al., 2011).”
BackgroundBono, C., Guerrero, P., Erades, A., Jordán‐Pla, A., Yáñez, A., & Gil, M. L. (2022) · Stem Cells · doi:10.1093/stmcls/sxac053 · Cited by 11
van Vliet, A. A., van den Hout, M. C. G. N., Steenmans, D., Duru, A. D., Georgoudaki, A., de Gruijl, T. D., van IJcken, W. F. J., Spanholtz, J., & Raimo, M. (2024) · Molecular Therapy Oncology · doi:10.1016/j.omton.2024.200870 · Cited by 14
Stress Hematopoiesis Is Regulated by the Krüppel-Like Transcription Factor ZBP-89
Li, X., Romain, R. D., Park, D., Scadden, D. T., Merchant, J. L., & Arnaout, M. A. (2013) · Stem Cells · doi:10.1002/stem.1598 · Cited by 10
Metadata
- Authors
- Rosenbauer, F., & Tenen, D. G.
- Affiliations
- Max Delbrück Center (DE)
- Harvard University (US)
- Venue
- Nature Reviews Immunology
- Published
- 2007-02
- Volume
- 7
- Issue
- 2
- Pages
- 105-117
- ISSN
- 1474-1733 (ISSN-L)
- 1474-1741
- OpenAlex
- W1980860344
- Cited by
- 606
- References
- 142
- Citations by year
- 2026: 20 · 2025: 20 · 2024: 21 · 2023: 24 · 2022: 29 · 2021: 17 · 2020: 21 · 2019: 28 · 2018: 30 · 2017: 45 · 2016: 31 · 2015: 42 · 2014: 38 · 2013: 43 · 2012: 27
- FWCI
- 5.86
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Immunology (publishedVersion)
- PubMed (publishedVersion)
- MDC Repository (Max-Delbrueck-Center for Molecular Medicine) (submittedVersion)
- Funders
- Lymphoma Research Foundation
- National Institutes of Health
- Topics
- Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Retinoids in leukemia and cellular processes
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Keywords
- transcription factors, myeloid development, myeloid differentiation, myeloid leukemia, differentiation block, transcription factor dysregulation, cell fate regulation
- MeSH terms
- Animals, Cell Differentiation, Cell Transformation, Neoplastic, Hematopoietic Stem Cells, Humans, Leukemia, Myeloid, Transcription Factors, Mice, Knockout, Cell Lineage, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.